NCT04716296View on ClinicalTrials.gov

Ketamine in Deep Brain Stimulation (DBS) Surgery

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

September 15, 2022

Study Completion Date

December 31, 2023

Conditions
Deep Brain Stimulation
Interventions
DRUG

Ketamine

Ketamine will be given for the second stage of the DBS surgery.

DRUG

Saline

Saline will be given for the second stage of the DBS surgery.

Trial Locations (1)

Unknown

Rabin Medical Center, Petah Tikva

All Listed Sponsors
lead

Rabin Medical Center

OTHER

NCT04716296 - Ketamine in Deep Brain Stimulation (DBS) Surgery | Biotech Hunter | Biotech Hunter